JW Pharmaceutical Corporation (KRX: 001060)
South Korea
· Delayed Price · Currency is KRW
23,900
+400 (1.70%)
Nov 15, 2024, 3:30 PM KST
JW Pharmaceutical Company Description
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally.
It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer.
The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment.
In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
JW Pharmaceutical Corporation
Country | South Korea |
Founded | 1945 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,064 |
Contact Details
Address: JW Gwacheon Tower, 38 Gwacheon-si, 13840 South Korea | |
Phone | 82 2 8406 777 |
Website | jw-pharma.co.kr |
Stock Details
Ticker Symbol | 001060 |
Exchange | Korea Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | KRW |
ISIN Number | KR7001060003 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Sung-Yeol Lee | Chief Executive Officer, Head of Product Development and Management and Director |
Young-Sub Shin | Chief Executive Officer, Head of Sales and Marketing and Inside Director |
Jae-Kwang Jeon | Head Managing Director and Head of Public Relation |
Hyun-seok Han | Head of Product Plant |
Kim Yong Kwan | Development Head and Internal Director |